Arcadia Biosciences Inc (RKDA) — Cash Flow-to-Debt Ratio
Arcadia Biosciences Inc (RKDA) has a Cash Flow-to-Debt Ratio of -0.36x as of December 2025, meaning its operating cash flow of $-861.00K could theoretically repay 0% of its total liabilities ($2.41 Million) in one year. Explore RKDA strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Arcadia Biosciences Inc Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Arcadia Biosciences Inc across 14 annual periods. Also explore Arcadia Biosciences Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Arcadia Biosciences Inc (2012–2025)
Year-by-year debt coverage analysis for Arcadia Biosciences Inc. For market capitalisation and broader financial context, see Arcadia Biosciences Inc (RKDA) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.97x | $-4.74 Million | $2.41 Million | ▼ -49.2% |
| 2024 | -1.32x | $-9.63 Million | $7.29 Million | ▲ +39.6% |
| 2023 | -2.18x | $-15.29 Million | $7.00 Million | ▼ -25.4% |
| 2022 | -1.74x | $-13.98 Million | $8.02 Million | ▲ +14.3% |
| 2021 | -2.03x | $-25.87 Million | $12.72 Million | ▼ -26.5% |
| 2020 | -1.61x | $-30.22 Million | $18.80 Million | ▼ -126.7% |
| 2019 | -0.71x | $-17.20 Million | $24.25 Million | ▲ +41.7% |
| 2018 | -1.22x | $-13.63 Million | $11.21 Million | ▲ +25.4% |
| 2017 | -1.63x | $-13.96 Million | $8.56 Million | ▼ -228.7% |
| 2016 | -0.50x | $-17.05 Million | $34.38 Million | ▼ -11.7% |
| 2015 | -0.44x | $-15.11 Million | $34.02 Million | ▲ +19.6% |
| 2014 | -0.55x | $-14.79 Million | $26.77 Million | ▼ -52.1% |
| 2013 | -0.36x | $-9.74 Million | $26.84 Million | ▲ +27.9% |
| 2012 | -0.50x | $-9.59 Million | $19.04 Million | — |